echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The new measures encourage merger and reorganization, and such drug distribution enterprises will benefit!

    The new measures encourage merger and reorganization, and such drug distribution enterprises will benefit!

    • Last Update: 2019-12-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [trends of pharmaceutical network industry] in recent years, with the continuous promotion and implementation of medical reform policies such as "4 + 7" volume procurement, the concentration of pharmaceutical circulation industry has been increasing, and small and medium-sized enterprises have gradually withdrawn from the market The industry believes that under the influence of the aging population and favorable medical policies, the pharmaceutical circulation industry is still expected to maintain a high degree of prosperity in the future, and the industry development level will gradually move towards internationalization However, the problems such as the relatively backward standardization of the industry and the low level of logistics informatization are the "obstacles" to the development of the industry At the same time, the problems such as the weak discourse power and the single profit model of drug distribution enterprises are prominent The author understands that in order to promote the transformation, upgrading and innovative development of drug distribution enterprises, Shaanxi Provincial Drug Administration recently released a proposal on promoting the rapid development of drug distribution industry The opinion focuses on nine aspects of drug operation approval mechanism, change process, merger and reorganization, storage resource integration, retail enterprise chain development, and promotes innovative measures that benefit enterprises and facilitate people Among them, for pharmaceutical distribution enterprises, the opinions encourages pharmaceutical production and marketing enterprises with modern pharmaceutical logistics conditions inside and outside the province to hold and participate in pharmaceutical wholesale enterprises in the province through merger, reorganization, joint development and other modes The pharmaceutical enterprise groups with modern logistics conditions are encouraged to upgrade and strengthen the acquired and merged enterprises by means of absorbing and operating business and legally divesting assets Encourage the pharmaceutical wholesale enterprises with modern logistics conditions to implement multi warehouse collaborative distribution in the group's enterprises (wholly-owned or holding subsidiaries), allow the establishment of warehouses in different places, third-party pharmaceutical entrusted storage and transportation business, unified cross regional centralized distribution, etc., and promote the merger and reorganization of pharmaceutical wholesale enterprises and limited integration of storage resources In addition, we should encourage diversified development of pharmaceutical trading enterprises, and allow pharmaceutical wholesale enterprises to increase their pharmaceutical retail chain business Pharmaceutical trading enterprises that have both wholesale and retail chains of pharmaceuticals may merge the wholesale and retail chain businesses of pharmaceuticals and apply for a unified pharmaceutical trading license From the above measures, we can see a signal: encourage the merger and reorganization of pharmaceutical wholesale enterprises, and pharmaceutical production and marketing enterprises in Shaanxi Province and outside with modern pharmaceutical logistics conditions are expected to usher in opportunities The author understands that this measure is basically consistent with the opinions issued by Shanxi Province in August, that is, to cultivate large-scale modern drug circulation backbone enterprises through merger and reorganization In addition, the opinions issued by Sichuan Province in 2018 also encouraged the merger and reorganization of drug distribution enterprises, built a unified and open market pattern with orderly competition, and promoted the cultivation of modern drug distribution backbone enterprises Different from Shaanxi Province, Shanxi Province also encourages enterprises to upgrade and transform new license issuing enterprises according to modern pharmaceutical logistics conditions when they are merged and reorganized At the time of merger and reorganization, pharmaceutical wholesale enterprises that have the conditions of modern pharmaceutical logistics and have no serious violations of laws and regulations may issue a new pharmaceutical trading license on the basis of not less than the original conditions of the merged pharmaceutical wholesale enterprises In general, under a series of new measures, the speed of merger, reorganization and integration of the pharmaceutical distribution industry will be further accelerated, and the industry concentration will continue to improve For qualified pharmaceutical distribution enterprises, a good environment is conducive to the growth and strength of enterprises, and at the same time, it can promote the transformation, upgrading, and innovation and development of enterprises.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.